HEADER HYDROLASE/ANTIBIOTIC 20-JAN-15 4S2I TITLE CTX-M-15 IN COMPLEX WITH AVIBACTAM COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: BLACTX-M-15; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.T.KING,N.C.J.STRYNADKA REVDAT 4 22-NOV-17 4S2I 1 REMARK REVDAT 3 28-SEP-16 4S2I 1 JRNL REVDAT 2 03-JUN-15 4S2I 1 HETSYN REVDAT 1 25-FEB-15 4S2I 0 JRNL AUTH D.T.KING,A.M.KING,S.M.LAL,G.D.WRIGHT,N.C.STRYNADKA JRNL TITL MOLECULAR MECHANISM OF AVIBACTAM-MEDIATED BETA-LACTAMASE JRNL TITL 2 INHIBITION. JRNL REF ACS INFECT DIS V. 1 175 2015 JRNL REFN ESSN 2373-8227 JRNL PMID 27622530 JRNL DOI 10.1021/ACSINFECDIS.5B00007 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 65626 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 3320 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.50 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4758 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2459 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4511 REMARK 3 BIN R VALUE (WORKING SET) : 0.2448 REMARK 3 BIN FREE R VALUE : 0.2655 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.19 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 247 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3883 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 546 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.23 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.12880 REMARK 3 B22 (A**2) : 0.27470 REMARK 3 B33 (A**2) : -1.40350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.33720 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.180 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.086 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3989 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5416 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1396 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 105 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 581 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3989 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 550 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6076 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.70 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.37 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 0.5222 12.7658 15.7774 REMARK 3 T TENSOR REMARK 3 T11: -0.0276 T22: -0.0313 REMARK 3 T33: -0.0423 T12: -0.0005 REMARK 3 T13: 0.0092 T23: -0.0016 REMARK 3 L TENSOR REMARK 3 L11: 0.6951 L22: 0.7958 REMARK 3 L33: 0.5879 L12: 0.5018 REMARK 3 L13: -0.0514 L23: -0.1898 REMARK 3 S TENSOR REMARK 3 S11: -0.0136 S12: 0.0764 S13: 0.0333 REMARK 3 S21: -0.0370 S22: 0.0156 S23: 0.0012 REMARK 3 S31: -0.0224 S32: -0.0192 S33: -0.0021 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 14.0104 18.6996 51.6923 REMARK 3 T TENSOR REMARK 3 T11: -0.0364 T22: -0.0300 REMARK 3 T33: -0.0403 T12: -0.0041 REMARK 3 T13: 0.0059 T23: 0.0100 REMARK 3 L TENSOR REMARK 3 L11: 0.9337 L22: 0.6320 REMARK 3 L33: 0.5370 L12: 0.0450 REMARK 3 L13: 0.0055 L23: -0.0247 REMARK 3 S TENSOR REMARK 3 S11: 0.0346 S12: -0.0374 S13: 0.0267 REMARK 3 S21: 0.0129 S22: -0.0149 S23: -0.0718 REMARK 3 S31: 0.0384 S32: 0.0211 S33: -0.0197 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4S2I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000088097. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08B1-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 (DCM) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65627 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 34.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULPHATE, 0.1M MES PH REMARK 280 6.5, 30% PEG 5K MME, 5MM AVIBACTAM, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.32500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS PROTEIN BEHAVES AS A MONOMER IN SOLUTION REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 25 REMARK 465 THR A 26 REMARK 465 GLY A 289 REMARK 465 LEU A 290 REMARK 465 GLN B 25 REMARK 465 THR B 26 REMARK 465 ALA B 27 REMARK 465 GLY B 289 REMARK 465 LEU B 290 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -140.42 51.54 REMARK 500 VAL A 103 -137.38 -119.59 REMARK 500 ASN A 106 72.23 -161.60 REMARK 500 SER A 220 -124.63 -101.44 REMARK 500 CYS B 69 -136.92 49.83 REMARK 500 VAL B 103 -138.91 -122.49 REMARK 500 ASN B 106 67.28 -159.09 REMARK 500 SER B 220 -129.89 -97.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NXL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NXL B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HBU RELATED DB: PDB REMARK 900 SAME PROTEIN-LIGAND COMPLEX BUT DIFFERENT SPACE GROUP. DBREF 4S2I A 25 290 UNP G3G192 G3G192_KLEPN 49 311 DBREF 4S2I B 25 290 UNP G3G192 G3G192_KLEPN 49 311 SEQRES 1 A 263 GLN THR ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU SEQRES 2 A 263 ARG GLN SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN SEQRES 3 A 263 THR ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU SEQRES 4 A 263 ARG PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA SEQRES 5 A 263 ALA ALA VAL LEU LYS LYS SER GLU SER GLU PRO ASN LEU SEQRES 6 A 263 LEU ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL SEQRES 7 A 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 A 263 MET SER LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 A 263 SER ASP ASN VAL ALA MET ASN LYS LEU ILE ALA HIS VAL SEQRES 10 A 263 GLY GLY PRO ALA SER VAL THR ALA PHE ALA ARG GLN LEU SEQRES 11 A 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 A 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 A 263 SER PRO ARG ALA MET ALA GLN THR LEU ARG ASN LEU THR SEQRES 14 A 263 LEU GLY LYS ALA LEU GLY ASP SER GLN ARG ALA GLN LEU SEQRES 15 A 263 VAL THR TRP MET LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 A 263 ILE GLN ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP SEQRES 17 A 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE SEQRES 18 A 263 ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU SEQRES 19 A 263 VAL THR TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER SEQRES 20 A 263 ARG ARG ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR SEQRES 21 A 263 ASP GLY LEU SEQRES 1 B 263 GLN THR ALA ASP VAL GLN GLN LYS LEU ALA GLU LEU GLU SEQRES 2 B 263 ARG GLN SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN SEQRES 3 B 263 THR ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU SEQRES 4 B 263 ARG PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA SEQRES 5 B 263 ALA ALA VAL LEU LYS LYS SER GLU SER GLU PRO ASN LEU SEQRES 6 B 263 LEU ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL SEQRES 7 B 263 ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR SEQRES 8 B 263 MET SER LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR SEQRES 9 B 263 SER ASP ASN VAL ALA MET ASN LYS LEU ILE ALA HIS VAL SEQRES 10 B 263 GLY GLY PRO ALA SER VAL THR ALA PHE ALA ARG GLN LEU SEQRES 11 B 263 GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR SEQRES 12 B 263 LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR SEQRES 13 B 263 SER PRO ARG ALA MET ALA GLN THR LEU ARG ASN LEU THR SEQRES 14 B 263 LEU GLY LYS ALA LEU GLY ASP SER GLN ARG ALA GLN LEU SEQRES 15 B 263 VAL THR TRP MET LYS GLY ASN THR THR GLY ALA ALA SER SEQRES 16 B 263 ILE GLN ALA GLY LEU PRO ALA SER TRP VAL VAL GLY ASP SEQRES 17 B 263 LYS THR GLY SER GLY GLY TYR GLY THR THR ASN ASP ILE SEQRES 18 B 263 ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO LEU ILE LEU SEQRES 19 B 263 VAL THR TYR PHE THR GLN PRO GLN PRO LYS ALA GLU SER SEQRES 20 B 263 ARG ARG ASP VAL LEU ALA SER ALA ALA LYS ILE VAL THR SEQRES 21 B 263 ASP GLY LEU HET NXL A 301 17 HET NXL B 301 17 HETNAM NXL (2S,5R)-1-FORMYL-5-[(SULFOOXY)AMINO]PIPERIDINE-2- HETNAM 2 NXL CARBOXAMIDE HETSYN NXL AVIBACTAM, BOUND FORM, NXL104, BOUND FORM FORMUL 3 NXL 2(C7 H13 N3 O6 S) FORMUL 5 HOH *546(H2 O) HELIX 1 1 ALA A 27 GLY A 41 1 15 HELIX 2 2 CYS A 69 THR A 71 5 3 HELIX 3 3 SER A 72 GLU A 85 1 14 HELIX 4 4 ASN A 89 ASN A 92 5 4 HELIX 5 5 LYS A 98 LEU A 102 5 5 HELIX 6 6 ILE A 108 HIS A 112 5 5 HELIX 7 7 LEU A 119 TYR A 129 1 11 HELIX 8 8 ASP A 131 GLY A 143 1 13 HELIX 9 9 GLY A 144 LEU A 155 1 12 HELIX 10 10 PRO A 167 THR A 171 5 5 HELIX 11 11 SER A 182 LEU A 195 1 14 HELIX 12 12 GLY A 200 GLY A 213 1 14 HELIX 13 13 SER A 220 LEU A 225 5 6 HELIX 14 14 ARG A 275 ASP A 288 1 14 HELIX 15 15 VAL B 29 GLY B 41 1 13 HELIX 16 16 CYS B 69 THR B 71 5 3 HELIX 17 17 SER B 72 GLU B 85 1 14 HELIX 18 18 SER B 86 ASN B 92 5 7 HELIX 19 19 LYS B 98 LEU B 102 5 5 HELIX 20 20 ILE B 108 VAL B 113 5 6 HELIX 21 21 LEU B 119 SER B 130 1 12 HELIX 22 22 ASP B 131 GLY B 143 1 13 HELIX 23 23 GLY B 144 LEU B 155 1 12 HELIX 24 24 PRO B 167 THR B 171 5 5 HELIX 25 25 SER B 182 LEU B 195 1 14 HELIX 26 26 GLY B 200 GLY B 213 1 14 HELIX 27 27 SER B 220 LEU B 225 5 6 HELIX 28 28 ARG B 275 ASP B 288 1 14 SHEET 1 A 5 GLN A 56 TYR A 60 0 SHEET 2 A 5 ARG A 43 ASN A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 A 5 LEU A 259 THR A 266 -1 O THR A 266 N ARG A 43 SHEET 4 A 5 THR A 243 TRP A 251 -1 N ALA A 248 O LEU A 261 SHEET 5 A 5 VAL A 230 GLY A 238 -1 N VAL A 230 O TRP A 251 SHEET 1 B 2 PHE A 66 ALA A 67 0 SHEET 2 B 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 C 2 ARG A 94 GLU A 96 0 SHEET 2 C 2 THR A 116 SER A 118 -1 O MET A 117 N VAL A 95 SHEET 1 D 5 GLN B 56 TYR B 60 0 SHEET 2 D 5 ARG B 43 ASN B 50 -1 N VAL B 46 O TYR B 60 SHEET 3 D 5 LEU B 259 THR B 266 -1 O TYR B 264 N GLY B 45 SHEET 4 D 5 THR B 243 TRP B 251 -1 N ALA B 248 O LEU B 261 SHEET 5 D 5 VAL B 230 GLY B 238 -1 N GLY B 236 O ASN B 245 SHEET 1 E 2 PHE B 66 ALA B 67 0 SHEET 2 E 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 F 2 ARG B 94 ILE B 97 0 SHEET 2 F 2 GLY B 115 SER B 118 -1 O MET B 117 N VAL B 95 LINK OG SER A 70 CAN NXL A 301 1555 1555 1.38 LINK OG SER B 70 CAN NXL B 301 1555 1555 1.40 CISPEP 1 GLU A 166 PRO A 167 0 3.65 CISPEP 2 GLU B 166 PRO B 167 0 1.31 SITE 1 AC1 13 CYS A 69 SER A 70 ASN A 104 TYR A 105 SITE 2 AC1 13 SER A 130 ASN A 132 ASN A 170 LYS A 234 SITE 3 AC1 13 THR A 235 GLY A 236 SER A 237 HOH A 516 SITE 4 AC1 13 HOH A 551 SITE 1 AC2 14 CYS B 69 SER B 70 ASN B 104 SER B 130 SITE 2 AC2 14 ASN B 132 ASN B 170 THR B 216 LYS B 234 SITE 3 AC2 14 THR B 235 GLY B 236 SER B 237 HOH B 505 SITE 4 AC2 14 HOH B 528 HOH B 575 CRYST1 62.010 60.650 71.500 90.00 104.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016126 0.000000 0.004021 0.00000 SCALE2 0.000000 0.016488 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014414 0.00000